Matches in Wikidata for { <http://www.wikidata.org/entity/Q73509458> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q73509458 description "artículu científicu espublizáu en xunu de 1997" @default.
- Q73509458 description "im Juni 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73509458 description "scientific article published on 01 June 1997" @default.
- Q73509458 description "wetenschappelijk artikel" @default.
- Q73509458 description "наукова стаття, опублікована в червні 1997" @default.
- Q73509458 name "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2" @default.
- Q73509458 name "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin" @default.
- Q73509458 type Item @default.
- Q73509458 label "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2" @default.
- Q73509458 label "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin" @default.
- Q73509458 prefLabel "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2" @default.
- Q73509458 prefLabel "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin" @default.
- Q73509458 P1433 Q73509458-226D474A-865C-4E50-9093-51CC506CFD90 @default.
- Q73509458 P1476 Q73509458-CF5F3001-5556-420E-865F-882D9DDC02A7 @default.
- Q73509458 P2093 Q73509458-133FD7EC-2B98-4BAA-89B6-F2E98D606E23 @default.
- Q73509458 P2093 Q73509458-386903F5-8E66-40A9-B076-D67620C3DBA7 @default.
- Q73509458 P2093 Q73509458-6A91DAE7-91F8-4DBF-A4F6-DE3B11756AB4 @default.
- Q73509458 P2093 Q73509458-8B6461F3-FBB8-4C39-B36D-5D519A4C5FA6 @default.
- Q73509458 P2888 Q73509458-F34F9932-801E-4272-9C9D-009E729B83FC @default.
- Q73509458 P304 Q73509458-37756FD4-F0DA-4137-BD16-83053B841865 @default.
- Q73509458 P31 Q73509458-F4A6EC82-07A1-4B9E-B2D2-D7E7FAF37097 @default.
- Q73509458 P356 Q73509458-A8FE7031-74A5-460A-9259-591B5A982255 @default.
- Q73509458 P433 Q73509458-80B462D7-A01C-44D6-8693-CFB5490815C9 @default.
- Q73509458 P478 Q73509458-49D35B96-6F3B-4BC1-990D-5D0A5F3FED91 @default.
- Q73509458 P577 Q73509458-AFFA5351-55F7-4E6B-88DF-35ABD1113CF0 @default.
- Q73509458 P6179 Q73509458-6D2C46BE-6DF4-44E7-9131-3EB029909B86 @default.
- Q73509458 P698 Q73509458-31A9A044-5117-4977-B9D9-A29A45DB614F @default.
- Q73509458 P356 S001250050728 @default.
- Q73509458 P698 9222642 @default.
- Q73509458 P1433 Q5270140 @default.
- Q73509458 P1476 "Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2" @default.
- Q73509458 P2093 "Kolb H" @default.
- Q73509458 P2093 "Martin S" @default.
- Q73509458 P2093 "O'Hara RM Jr" @default.
- Q73509458 P2093 "Rothe H" @default.
- Q73509458 P2888 s001250050728 @default.
- Q73509458 P304 "641-646" @default.
- Q73509458 P31 Q13442814 @default.
- Q73509458 P356 "10.1007/S001250050728" @default.
- Q73509458 P433 "6" @default.
- Q73509458 P478 "40" @default.
- Q73509458 P577 "1997-06-01T00:00:00Z" @default.
- Q73509458 P6179 "1046290447" @default.
- Q73509458 P698 "9222642" @default.